PCI Biotech second half 2023 interim results
February 14, 2024 01:00 ET
|
PCI Biotech Holding ASA
Oslo (Norway), 14 February 2024 – PCI Biotech (OSE: PCIB), today announces its interim second half 2023 results. Please find enclosed the interim report and presentation. Highlights review ...
PCI Biotech: Invitation to second half interim 2023 results presentation
February 12, 2024 03:26 ET
|
PCI Biotech Holding ASA
Oslo, Norway, 12 February 2024 - PCI Biotech (OSE: PCIB) invites to a webcast presentation of the company's second half 2023 interim report on Wednesday 14 February 2024, 08:30am – 09:30am CET (local...
PCI Biotech initiates field testing of its proprietary technology for gene therapy manufacturing
October 13, 2023 04:17 ET
|
PCI Biotech Holding ASA
Oslo, Norway, 13 October 2023 – PCI Biotech (OSE: PCIB) today announced a research collaboration agreement with the aim to address critical pain points in the manufacturing of gene therapies. The...
PCI Biotech: European patent for mRNA delivery with fimaNAc
September 07, 2023 06:36 ET
|
PCI Biotech Holding ASA
Oslo (Norway), 7 September 2023 – PCI Biotech (OSE: PCIB), a biopharmaceutical company, today announces that the European Patent Office (EPO) has informed PCI Biotech that they intend to grant a new...
PCI Biotech: Employee share option scheme
September 04, 2023 04:14 ET
|
PCI Biotech Holding ASA
Oslo, 4 September 2023 - PCI Biotech (OSE: PCIB), today announce that the Board of Directors has granted share options to key employees. In accordance with the authorisation granted by the...
PCI Biotech: Write-down of share capital registered
September 01, 2023 05:04 ET
|
PCI Biotech Holding ASA
Oslo, Norway, 1 September 2023 – PCI Biotech Holding ASA (OSE: PCIB) Reference is made to the resolution made by the Annual General Meeting 25 May 2023, in respect of a write-down of share capital by...
PCI Biotech first half 2023 interim results
August 31, 2023 01:00 ET
|
PCI Biotech Holding ASA
Oslo (Norway), 31 August 2023 – PCI Biotech (OSE: PCIB), today announces its interim first half 2023 results. Please find enclosed the report and presentation.Highlights review fimaNAc –...
PCI Biotech: Invitation to first half interim 2023 results presentation
August 25, 2023 08:30 ET
|
PCI Biotech Holding ASA
Oslo, Norway, 25 August 2023 - PCI Biotech (OSE: PCIB) invites to a webcast presentation of the company's first half 2023 interim report on Thursday 31 August 2023, 08:30am – 09:30am CEST (local...
Minutes from Annual General Meeting 2023
May 25, 2023 05:38 ET
|
PCI Biotech Holding ASA
Oslo, 25 May 2023. The Annual General Meeting in PCI Biotech Holding ASA took place today, 25 May 2023. All the matters on the agenda were approved and the minutes of the Annual General Meeting are...
Disclosure of voting rights for Chairman of the Board
May 24, 2023 04:43 ET
|
PCI Biotech Holding ASA
Oslo, 24 May 2023. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of its chairman, Hans Peter Bøhn. Hans Peter Bøhn is chairman of PCI Biotech and shall...